A randomized phase III trial evaluating the role of axillary lymph node dissection in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy

BH-14-211
Cancer - Breast
Seth Kaufman, MD
D’Amour Center for Cancer Care
The purpose of this study is to examine whether removing some of the lymph nodes from the arm pit, but not removing them all followed with radiation therapy (experimental) will be as good as having the majority of the lymph nodes from the arm pit removed during breast surgery followed with radiation (standard of care).
Stage T1-3 breast cancer; non-metastatic; no history of ipsilateral breast cancer or ipsilateral axillary surgery
Rae Lynn Defeo
413-794-0255